United States · 
Who invested in Immunis, Inc.?
Immunis, Inc.'s investors include Bold Capital Partners, Remiges Ventures, Continuum Health Ventures, Lifespan Vision Ventures and JLS Fund.
United States · Series A startup
Who invested in Immunis, Inc.
Funding summaryUpdated 26 Oct 2026
$25Mraised across 1 round since 2025, from 1 source
- Latest round
- Series A, $25MJan 2025
- Investors
- 5
The rounds
- Jan 2025Series A$25M
Reported by Firms' own news pagesSEC filing: $20M sold, first sale Jun 2024
Founders and team
From Immunis, Inc.'s own website: 3 on the team.
- Abbey AbrechtSenior Quality Assurance Manager
- Joelle HafenSenior Director of Operations
- Taka KodaBoard Member
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Immunis, Inc.
How much has Immunis, Inc. raised?
Immunis, Inc. has raised $25M across 1 round since 2025.
When did Immunis, Inc. last raise?
Immunis, Inc.'s most recent round was a Series A of $25M in Jan 2025.
What was Immunis, Inc.'s biggest round?
Its most recent round, $25M in Jan 2025, is also its largest on record.
Who backed Immunis, Inc. first?
Immunis, Inc.'s first round on record, in Jan 2025, was backed by Bold Capital Partners, Remiges Ventures and Continuum Health Ventures and 2 others.
What stage is Immunis, Inc. at?
Immunis, Inc.'s latest named round is a Series A, in Jan 2025.
Where is Immunis, Inc. based?
Immunis, Inc. is based in the United States.
Companies like Immunis, Inc.
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.